Scheinman Melvin
J Atr Fibrillation. 2016 Dec 31;9(4):1506. doi: 10.4022/jafib.1506. eCollection 2016 Dec.
This essay is a brief review of advances in treatment of patients with supraventricular tachycardia (SVT) over the past 55 years. We review the knowledge base available in terms of arrhythmia diagnosis and the limited availability of drug therapy. Significant advances resulted in the introduction of direct-current defibrillators as well as introduction of ambulatory ECG recordings. We also witnessed a tremendous increase in an understanding of the mechanisms of SVT which in turn led to the development of first surgical and subsequently catheter based techniques for localization and ablation of foci or pathways responsible for arrhythmias. More recently, surgical and catheter techniques have been introduced in an attempt to cure atrial fibrillation. These techniques have proven especially effective for those with paroxysmal atrial fibrillation and less effective for those with long standing persistent fibrillation. The future brings hope for more extensive use of non-invasive techniques both to diagnose arrhythmia mechanisms together with techniques to ablate cardiac foci without patient instrumentation and finally in the use of gene therapy for patients with cardiac arrhythmia.
本文简要回顾了过去55年室上性心动过速(SVT)患者治疗方面的进展。我们回顾了心律失常诊断方面的现有知识基础以及药物治疗的有限可用性。重大进展包括直流电除颤器的引入以及动态心电图记录的出现。我们还见证了对SVT机制理解的巨大提升,这反过来又促使了首先是外科手术,随后是基于导管的技术的发展,用于定位和消融导致心律失常的病灶或路径。最近,外科手术和导管技术已被引入以尝试治愈心房颤动。这些技术已证明对阵发性心房颤动患者特别有效,而对长期持续性心房颤动患者效果较差。未来有望更广泛地使用非侵入性技术,既用于诊断心律失常机制,也用于在无需患者植入设备的情况下消融心脏病灶的技术,最终用于心律失常患者的基因治疗。